Search

Search Constraints

You searched for: Author/Creator Tournadre, A

Search Results

1. AB0696 Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in auvergne (france). (15th June 2017)

6. FRI0234 Choice of biologic therapy following rituximab: influencing factors in a french multicenter cohort of rheumatoid arthritis. (15th June 2017)

7. SAT0117 Retention rates of adalimumab, etanercept, and infliximab as 1st- or 2nd-line biotherapy for rheumatoid arthritis patients in daily practice in auvergne. (15th June 2017)